Systemic disease at diagnosis predicts earlier death in Sjögren syndome

People with evidence of systemic disease at the time of diagnosis have reduced long-term survival compared to people with simple sicca or dryness symptoms. INTRODUCTION Sjögren syndrome is an autoimmune disease where the body’s immune system attacks glands that produce fluids, for example the lacrimal and salivary glands. The disease mainly affects women between the […]

Read More…

Inflammation raises the risk of heart attack and stroke in people with rheumatoid arthritis

Coronary heart disease is a common cause of death in people with rheumatoid arthritis, and may be linked to systemic inflammation. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. Patients with rheumatoid arthritis often have a higher risk of developing cardiovascular diseases such as coronary heart […]

Read More…

In RA, etanercept can usually not be stopped, but in some patients who are doing well the dose may be reduced

Rheumatoid arthritis patients who have stable and improved symptoms should continue long-term maintenance treatment on full- or low-dose etanercept. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints and sometimes their internal organs, causing pain and disability. Etanercept is one of a group of medicines called biologics that are used to […]

Read More…

New recommendations for treat-to-target in rheumatoid arthritis

Treating to target by measuring disease activity and regularly adjusting therapy results in the best outcomes for people with rheumatoid arthritis. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints and sometimes their internal organs, causing pain and disability. Treat-to-target is an important way of managing people with rheumatoid arthritis. Treating […]

Read More…